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SAF E HANDLING

Change Management Is a Consideration Beyond the Pandemic
Thoughtful Application Can Reduce Resistance and Improve Overall
Operations, If Consistent Steps Are Followed

BY K E N N E T H M A X I K , M B A , M B B , FAC H E ; C R A I G K I M B L E , P H A R M D , M B A , M S , B C AC P ; A N D A L B E R T O C O U S TA S S E HENCKE, DRPH, MD, MBA, MPH

D

URING THE CORONAVIRUS disease

2019 (COVID-19) pandemic,
organizations have promoted concepts
such as “We are in this together” to ensure
buy-in and build communication with
employees and the public.
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However, we should consider postpandemic times. We do not always
have a crisis to solve or a critical body
of evidence to point to when we need
to change a work process, influence
employees to support changes, improve
products, or increase medication safety. As
leaders, we should always ask ourselves: Is
change necessary? How do we effectively
implement the change? How do we articulate the benefits of the change? How do we
sustain efforts after the change?
Change management (CM) is a
well-organized framework for managing
the people side of change. 1 It includes
practices, processes, and planned activities
designed to facilitate and lead
organizations to move from the present
state to a desired state. 2 The goal of CM is
not to eliminate resistance but to anticipate
it, proactively plan for it, continuously
manage it, and mitigate the consequences. 3
In some settings, such as hospitals,
there are important challenges to changing
processes. Clinicians have high individual
autonomy and show various degrees of
professional dominance over management
and patients, which gives them control
and power. 4,5 CM practices are often only
considered retrospectively in practice
after challenges or implementation
difficulty occur. 6
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Step 1: Identifying What Needs to
Be Changed

The first step in most CM models is identifying what needs to be changed. A good way
to examine this in health care is the Swiss
cheese model related to patient safety.7
Perhaps the task or item is not meeting
expectations or there is a need to increase
effectiveness, operational efficiency, patient
safety, or productivity. In either event,
the element that needs to be changed is
identified. Then we recognize what exactly
should change, who will be affected, and
who the stakeholders are. Leadership must
realize that change may not be positive
for all stakeholders and may be perceived
as negative by some.
An example is rationing products for
personal protective equipment (PPE)
during supply chain disruptions from the
pandemic. Another is increasing telepharmacy use to provide care and education
to patients while protecting clinicians
and patients from unnecessary exposure
to COVID-19 and advancing medication
management and safety. In these cases,
what needed to change was apparent to
those involved. If a patient could not come
to the clinic to get care or equipment was
not available, an alternative was required.

Step 2: Determining the New Way of
Doing Business

Once a needed change is identified, a new
process should be identified. One case
in pharmacy practice is using alternative
compounded products instead of commercially available products to address supply
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chain shortages caused by stressors during
the pandemic. A matrix can be developed to
aid in this process, such as the Six Thinking
Hats, in which various points of view are
considered to evaluate the best ideas.8 This
type of thinking can help determine the best
choice and provide feedback to stakeholders
about why the option(s) being proposed are
better. This will allow the proposed change
to build critical mass to support the change.

Step 3: Implement and Maintain

To implement and sustain change, it must
address who is going to do what and when.
An example would be inventory-control
functions for the COVID-19 vaccine
supply. Everyone involved with the supply
chain and planning needs to understand
their role. The COVID-19 vaccine supply
chain includes managing cold storage,
thawing, and complex administration and
scheduling processes.
Once a plan is in place, stakeholders
need to be informed that the change is
starting. Once implemented, it should be
determined if the results were obtained.
Depending on the change, a new policy
may be written and employees trained
accordingly to sustain the change. Step 3 is
the point in which CM can fail and cause
a new process to increase the number of
errors in the short term, if the new standard
work is not written clearly. Finally, there is
a need to codify the change so the process
does not backslide over time.

Conclusion

The pandemic has caused leadership to
implement change more rapidly than usual
and rethink how business and process
operates, including managing the supply

In some settings,
such as hospitals,
there are important
challenges to
changing processes.
chain, deploying staff, ensuring medication
safety, and using personal protective equipment. Additionally, to effectively manage
identified change, CM should encompass
a standardized procedure. Although CM
can be a daunting process, a thoughtful
application will reduce the resistance to
change and improve overall operations,
regardless of where it is applied if it
follows consistent steps. ■
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